Author: The Business Outlook

The arrival of the New Year often coincides with an increase in illnesses, ranging from the common cold and flu to COVID. Dealing with these ailments can be uncomfortable, causing symptoms such as sore throat, brain fog, joint pain, headache, and congestion. While it might be challenging to summon the energy for cooking, consuming small, regular meals and staying hydrated can contribute to relief. Certain foods can play a crucial role in fighting inflammation and easing discomfort during illness.Beth Czerwony, a registered dietitian at Cleveland Clinic’s Center for Human Nutrition, emphasizes the healing potential of food during illnesses. Here are…

Read More
AI

Increasing numbers of travelers are abandoning tightly packed itineraries filled with activities from sunrise to sunset. Instead, they are opting to peruse pillow menus and retire early, marking the rise of sleep tourism. In this era, a growing array of hotels are providing services and amenities, including access to in-house sleep experts, to facilitate a restful experience for guests. The sleep tourism market is anticipated to expand by nearly 8%, reaching over $400 billion between 2023 and 2028, as per an analysis by HTF Market Intelligence.Rebecca Robbins, a sleep scientist at Harvard’s Division of Sleep Medicine and co-author of Sleep…

Read More

eBay Inc., an online retail platform, is set to pay a $3 million fine to settle criminal charges stemming from a harassment campaign carried out by its employees. These employees sent live spiders, cockroaches, and other unsettling items to the residence of a Massachusetts couple, as detailed in court documents filed on Thursday.The Justice Department has accused eBay of stalking and other offenses in a criminal information, with charges coming more than three years after the employees involved faced prosecution for their extensive efforts to intimidate David and Ina Steiner. The Steiners were targeted due to their production of an…

Read More

US regulators have granted temporary approval for the importation of a variant of penicillin used to treat syphilis due to a shortage of Pfizer Inc.’s version of the drug and a surge in syphilis cases. The Food and Drug Administration (FDA) has authorized the importation of penicillin G benzathine from French company Laboratoires Delbert, as Pfizer’s Bicillin L-A, the sole available version in the US, has faced shortages since April.Penicillin G benzathine is the preferred treatment for syphilis and the only medication for the congenital form of the disease, which caused numerous fatalities among babies and fetuses in 2022. In…

Read More

Data analysts utilize mathematical and analytical techniques to convert data into informed business decisions. With the escalating volume of available data, there is a growing demand for skilled data analysts, resulting in competitive salaries. In this article, we will explore the average earnings of data analysts and the factors influencing their salaries, such as experience, industry, location, and job title. Additionally, we’ll discuss strategies to enhance earning potential for those interested in entering or advancing in the field of data analysis.Average Data Analyst Salary:As of December 2022, the average salary for a data analyst in the United States is $66,859,…

Read More

Carta, the company responsible for managing cap tables for around 40,000 privately funded startups, is exiting the secondary trading business. This decision comes in the wake of a conflict of interest scandal, prompting the company to temporarily halt sales outreach for its primary business.In a blog post on Monday, Carta CEO Henry Ward announced the company’s withdrawal from the secondary trading business to address concerns about potential conflicts of interest with founders. The move follows accusations of self-dealing raised by the CEO of Linear on social media over the weekend, alleging that Carta used his startup’s confidential data without permission…

Read More

Mendus AB (“Mendus” publ; IMMU. ST), a biopharmaceutical firm with a focus on immunotherapies targeting tumors, has announced its participation in upcoming investor and industry conferences:42nd Annual J.P. Morgan Healthcare ConferenceLocation: San Francisco, USADate: January 8-11, 2024Mendus management will be in San Francisco for business and investor meetings during the J.P. Morgan conference.J.P. Morgan Healthcare Conference13th Annual LifeSci Partners Corporate Access EventLocation: San Francisco, USADate: January 8-10, 2024Mendus will participate in the LifeSci Corporate Access investor event.LifeSci Partners Corporate Access EventRedeye Theme: Fight CancerLocation: Stockholm, SwedenDate: January 24, 2024Mendus CEO Erik Manting will present the company and join a discussion…

Read More

On Friday, the Food and Drug Administration (FDA) granted approval for Florida’s groundbreaking plan to import prescription drugs from Canada. Governor Ron DeSantis, a Republican, had signed the plan into law in 2019, and its implementation awaited federal clearance from the FDA, which oversees prescription drug imports.President Joe Biden, a Democrat, has endorsed such initiatives to address the longstanding issue of high drug prices in the United States. In 2021, he issued an executive order directing the FDA to collaborate with states on drug imports.This policy shift signifies a departure from years of resistance by the pharmaceutical industry, which had…

Read More

On Thursday, Eli Lilly and Co. issued a warning against the non-medical use of its popular diabetes and weight loss drugs, Mounjaro and Zepbound, due to a surge in demand leading to nationwide shortages. The pharmaceutical company emphasized that these drugs, classified as GLP-1s, are intended for treating serious conditions such as Type 2 diabetes and obesity, not for cosmetic weight loss purposes.In an open letter dated January 4, Eli Lilly stressed that Mounjaro, approved in the spring of 2022, is designated for individuals with Type 2 diabetes, while Zepbound, approved in late 2023, is intended for those with obesity…

Read More

The recent completion of the 35th 5G benchmark study by the publisher involved a collaboration with Accuver Americas and Spirent Communications. This independent benchmark study focused on 5G 4CC using T-Mobile’s commercial 5G network in rural South Carolina, with Ericsson serving as the RAN infrastructure supplier.The report’s highlights include:Acknowledgements: The study was a joint effort with Accuver Americas (XCAL-M and XCAP) and Spirent Communications (Umetrix Data). The publisher was responsible for data collection, analysis, and commentary.Methodology: Using a Galaxy S23 smartphone, the study tested downlink performance in a cluster of 10 Gbps cell sites with 1180 MHz of Band n41,…

Read More